Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| argenx SEADR(ARGX) | 82,150 | 92,500 | +10,350 | $35.33M | $50.14M | 24.88% | +$14.81M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 922,100 | 663,381 | -258,719 | $37.86M | $34.75M | 17.24% | -$3.11M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 875,000 | 1,504,307 | +629,307 | $9.01M | $27.20M | 13.49% | +$18.19M |
| Cytokinetics, Incorporated(CYTK) | 190,000 | 466,813 | +276,813 | $10.29M | $24.65M | 12.23% | +$14.35M |
| Axsome Therapeutics, Inc.(AXSM) | 290,772 | 209,632 | -81,140 | $23.41M | $18.84M | 9.35% | -$4.57M |
| Avadel Pharmaceuticals Plc | 1,138,178 | 1,100,000 | -38,178 | $16.00M | $14.43M | 7.16% | -$1.58M |
| Protagonist Therapeutics Inc | 355,000 | 240,000 | -115,000 | $12.30M | $10.80M | 5.36% | -$1.50M |
| Pliant Therapeutics, Inc.(PLRX) | 232,200 | 380,000 | +147,800 | $2.50M | $4.26M | 2.11% | +$1.76M |
| TScan Therapeutics, Inc.(TCRX) | 0 | 825,341 | +825,341 | $0 | $4.11M | 2.04% | +$4.11M |
| Atyr Pharma Inc | 1,946,477 | 1,736,477 | -210,000 | $3.04M | $3.06M | 1.52% | +$19.7K |
| Soleno Therapeutics Inc | 19,695 | 57,983 | +38,288 | $803.6K | $2.93M | 1.45% | +$2.12M |
| Cidara Therapeutics Inc | 145,417 | 182,426 | +37,009 | $1.74M | $1.96M | 0.97% | +$224.8K |
| Stoke Therapeutics, Inc.(STOK) | 0 | 157,514 | +157,514 | $0 | $1.94M | 0.96% | +$1.94M |
| Disc Medicine, Inc.(IRON) | 0 | 25,543 | +25,543 | $0 | $1.26M | 0.62% | +$1.26M |
| Trevi Therapeutics, Inc.(TRVI) | 500,089 | 250,000 | -250,089 | $1.49M | $835.0K | 0.41% | -$655.3K |
| Allakos Inc | 649,957 | 649,957 | 0 | $650.0K | $424.6K | 0.21% | -$225.4K |
| Applied Therapeutics Inc | 227,470 | 0 | -227,470 | $1.06M | $0 | — | -$1.06M |
| Corcept Therapeutics Incorporated(CORT) | 244,750 | 0 | -244,750 | $7.95M | $0 | — | -$7.95M |
| Kymera Therapeutics, Inc.(KYMR) | 82,000 | 0 | -82,000 | $2.45M | $0 | — | -$2.45M |